Background and purpose Patients with acute stroke and mild or rapidly improving symptoms
frequently show progression. The role of reperfusion treatment in such patients is not clear …

Background and Purpose—Only a small percentage of stroke patients are treated with
thrombolytic therapy. We sought to determine whether vessel occlusion in mild strokes …

Background: Thrombolysis is often withheld from acute ischemic stroke patients presenting
with mild symptoms; however, up to 40% of these patients end up with a poor outcome when …

Background Untreated acute mild stroke patients have substantial 90-day disability rates
and worse outcomes than those who are treated with thrombolysis. There is little information …

Objective: To determine the frequency of early neurologic deterioration with infarct
expansion (ENDIE) and poor outcomes among ischemic stroke patients not treated with …

Several recent studies have shown that patients presenting with mild acute ischemic stroke
(mAIS) symptoms may have an unfavorable natural history. The presence of associated …

Background and Purpose—Unclear-onset strokes are generally excluded from time-based
thrombolytic therapy. We examined the safety and feasibility of magnetic resonance imaging …

Background Mild deficit is a relative contraindication to administration of intravenous
recombinant tissue plasminogen activator (IV rtPA) for acute ischemic stroke. However, what …

Background Optimal treatment strategy in patients with mild ischemic stroke remains
uncertain. While functional dependency or death has been reported in up to one-third of non …

OBJECTIVE: The objective of this study was to determine the proportion of stroke patients
presenting in an extended time window who have a thrombolytic treatment target …